COVID-19, Pfizer Reports Its Vaccine Is 100% Effective In Adolescents

The Pfizer / BioNTech vaccine has been shown to be 100% effective in adolescents 12-15 years of age, with or without prior evidence of SARS-CoV-2 infection. This is stated in a statement from BioNTech, where they detail the positive results of the BNT162b2 vaccine, in a phase 3 trial.

The trial demonstrated 100% efficacy and robust antibody responses, superior to those previously reported with participants ages 16 to 25, and was well tolerated, according to a statement from BioNTech, the German pharmaceutical partner of US-based Pfizer.

Albert Bourla, president and CEO of Pfizer, said the intention is to submit an application for authorization to the US agency FDA and other regulatory bodies in order to start vaccinating in that age group before the start of the next school year.

 

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *